(Q36645260)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Progestogens in cardiovascular diseases: an introduction to the epidemiologic data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

main subject

cardiovascular disease

1 reference

J I Mann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 March 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Obstetrics and Gynecology

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

6 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

752-757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

Female sex hormones and thrombosis. Epidemiological aspects

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Thrombosis with low-estrogen oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Myocardial infarction in young women with special reference to oral contraceptive practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Oral contraceptives and death from myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Oral-contraceptive use in relation to myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

Contraceptive methods: risks and benefits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932483-8

10.1016/S0002-9378(16)32483-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7065056%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference